MTOR and diabetic kidney disease: In DKD models, it has been shown that blocking KCa3.1 reverses diabetes-inhibited tubular autophagy and thus improves renal fibrosis, which is mediated by inhibiting the activation of the PI3K/Akt/mTOR signaling pathway (Huang et al., 2016).